Sponsor

Sun Pharma Advanced Research Company Limited

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Sun Pharma Advanced Research Company Limited appears in 12 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials12
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

12 shown
A Study in Patients With Advanced Breast CancerNCT04942054 · lead sponsor · 2022-05-20
TERMINATED
To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast CancerNCT04332549 · lead sponsor · 2020-04-27
WITHDRAWN
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706NCT03655236 · lead sponsor · 2019-02-18
TERMINATED
Evaluation of Safety and Efficacy of PDP-716NCT03450629 · lead sponsor · 2018-09-13
COMPLETED
Safety and Tolerability Study of K0706 in Subjects With Parkinson's DiseaseNCT02970019 · lead sponsor · 2017-03-30
COMPLETED
Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast CancerNCT03109249 · lead sponsor · 2017-01-14
COMPLETED
Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast CancerNCT02136927 · lead sponsor · 2014-08-01
TERMINATED
Study of SPARC1103 in Subjects With SpasticityNCT02027025 · lead sponsor · 2014-04-21
COMPLETED
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316NCT02041221 · lead sponsor · 2014-01-01
COMPLETED
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular HypertensionNCT00945958 · lead sponsor · 2010-11-01
COMPLETED
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular HypertensionNCT00947661 · lead sponsor · 2010-07-01
COMPLETED
Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian CancerNCT03055143 · lead sponsor · 2008-09-03
COMPLETED

Sponsor roles

lead sponsor12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.